Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- SMTC +2.8%, LH +0.9% (guidance), DV +0.6% (closes Scibids acquisition; provides updates to guidance)
Other news:
- KITT +17.4% (enters service contract with Shell plc (SHEL))
- AMC +7.5% (completes at-the-market equity offering)
- SCNI +5.3% (reports preclinical results for plaque psoriasis treatment)
- AVXL +4.4% (announces that a follow-on analysis of the landmark Phase 2b/3 study to treat early Alzheimer's disease with the investigational drug blarcamesine did demonstrate a statistically significant slowing in cognitive decline associated with Alzheimer's disease)
- HSTM +4.3% (authorizes new $10 mln share repurchase program)
- YUMC +3.9% (unveils "RGM 2.0" strategy and introduces 3-year financial targets at 2023 Investor Day)
- DVAX +2.3% (supply agreement with Avecia)
- DDD +2.1% (DDD delivers signed merger agreement to SSYS)
- SSYS +2% (DDD delivers signed merger agreement to SSYS)
- FFIE +2% (delivered its vehicle to realtor and Netflix Star Jason Oppenheim at the "Delivery Co-Creation Day")
- TRIN +1.8% (increases dividend)
Analyst comments:
- ETSY +3.6% (upgraded to Outperform from Peer Perform at Wolfe Research)
- FSLR +2.2% (upgraded to Outperform from Market Perform at BMO Capital Markets)
- NCLH +2% (upgraded to Buy from Neutral at Redburn Atlantic)
- CCL +1.7% (upgraded to Buy from Neutral at Redburn Atlantic)